Ortivus Logo

Ortivus

ISIN: SE0000188930 | Ticker: ORTI | LEI: 549300AVDV7UC14MTH79
Sector: Health CareSub-Industry: Health Care Equipment
Country: Sweden

About Ortivus

Company Description

With more than 30 years of experience in cardiology and medical technology, we are today one of the market leaders in e-health. We are still a tight and flexible organisation where each individual employee has a significant impact. It is also our employees’ knowledge and commitment that is creating value and success for our customers. Together we make a difference in people’s lives. For real.

Year founded

1985

Served area

Europe

Headquarters

Ortivus AB Svärdvägen 19, 18233 Danderyd – Sweden

Financial statements

Download as Excel
Line item in (sek) 01.01.2021 01.01.2022 01.01.2023
Assets 66,550,000.00 72,459,000.00 89,750,000.00
Noncurrent Assets 10,266,000.00 17,087,000.00 23,500,000.00
Property Plant And Equipment 1,702,000.00 1,939,000.00 2,160,000.00
Intangible Assets Other Than Goodwill 7,263,000.00 11,635,000.00 15,047,000.00
Other Noncurrent Financial Assets 1,497,000.00 0.00 N/A
Other Noncurrent Nonfinancial Assets 1,301,000.00 3,513,000.00 N/A
Current Assets 56,284,000.00 55,372,000.00 66,250,000.00
Inventories 3,489,000.00 4,777,000.00 14,397,000.00
Current Trade Receivables N/A 21,406,000.00 32,859,000.00
Other Current Receivables N/A 849,000.00 1,945,000.00
Cash and cash equivalents 22,127,000.00 22,112,000.00 7,597,000.00
Cash Equivalents 22,127,000.00 22,112,000.00 N/A
Equity And Liabilities 66,550,000.00 72,459,000.00 89,750,000.00
Equity 19,678,000.00 29,444,000.00 N/A
Issued Capital 15,508,000.00 15,508,000.00 15,508,000.00
Retained Earnings -28,661,000.00 -19,450,000.00 -13,558,000.00
Share Premium 32,787,000.00 32,787,000.00 N/A
Other Reserves 44,000.00 599,000.00 N/A
Additional Paidin Capital N/A 32,787,000.00 32,787,000.00
Equity Attributable To Owners Of Parent 19,678,000.00 29,444,000.00 35,435,000.00
Liabilities 46,872,000.00 43,015,000.00 54,315,000.00
Noncurrent Liabilities 140,000.00 12,090,000.00 11,073,000.00
Noncurrent Payables 140,000.00 2,041,000.00 N/A
Noncurrent Contract Liabilities N/A 10,049,000.00 6,909,000.00
Other Noncurrent Financial Liabilities 0.00 10,049,000.00 N/A
Current Liabilities 46,732,000.00 30,925,000.00 43,242,000.00
Trade And Other Current Payables 3,760,000.00 2,860,000.00 16,303,000.00
Current Accruals And Current Deferred Income Including Current Contract Liabilities N/A 16,175,000.00 18,069,000.00
Current Contract Liabilities N/A 7,302,000.00 1,592,000.00
Current Advances 24,122,000.00 7,302,000.00 N/A
Other Current Financial Liabilities 868,000.00 1,269,000.00 N/A
Other Current Liabilities N/A 3,319,000.00 5,304,000.00
Line item in (sek) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue 107,582,000.00 94,272,000.00 104,509,000.00
Other Income 8,986,000.00 3,204,000.00 1,606,000.00
Profit Loss From Operating Activities 11,392,000.00 9,346,000.00 5,847,000.00
Finance Income 37,000.00 31,000.00 0.00
Finance Costs 97,000.00 166,000.00 34,000.00
Insurance Finance Income Expenses From Insurance Contracts Issued Recognised In Profit Or Loss -60,000.00 -135,000.00 N/A
Cumulative Gain Loss Previously Recognised In Other Comprehensive Income Arising From Reclassification Of Financial Assets Out Of Fair Value Through Other Comprehensive Income Into Fair Value Through Profit Or Loss Measurement Category -409,000.00 555,000.00 N/A
Profit Loss Before Tax 11,332,000.00 9,211,000.00 5,813,000.00
Income Tax Expense Continuing Operations 0.00 0.00 -79,000.00
Profit (loss) 11,332,000.00 9,211,000.00 5,892,000.00
Profit Loss Attributable To Owners Of Parent 11,332,000.00 9,211,000.00 5,892,000.00
Line item in (sek) 01.01.2021 01.01.2022 01.01.2023
Profit (loss) 11,332,000.00 9,211,000.00 5,892,000.00
Adjustments For Reconcile Profit Loss N/A 5,446,000.00 1,090,000.00
Adjustments For Decrease Increase In Inventories 525,000.00 -1,273,000.00 -9,620,000.00
Adjustments For Decrease Increase In Other Operating Receivables -16,592,000.00 1,630,000.00 -15,774,000.00
Adjustments For Increase Decrease In Trade Account Payable 22,859,000.00 -7,240,000.00 N/A
Adjustments For Reconcile Profit Loss N/A 5,446,000.00 1,090,000.00
Cash Flows From Used In Operations 18,630,000.00 7,774,000.00 -6,878,000.00
Purchase Of Property Plant And Equipment Classified As Investing Activities 1,783,000.00 896,000.00 1,089,000.00
Purchase Of Intangible Assets Classified As Investing Activities 950,000.00 5,806,000.00 5,004,000.00
Purchase Of Other Longterm Assets Classified As Investing Activities N/A 0.00 56,000.00
Cash Flows From Used In Investing Activities -2,733,000.00 -6,702,000.00 -6,149,000.00
Repayments Of Borrowings Classified As Financing Activities 1,309,000.00 0.00 N/A
Payments Of Lease Liabilities Classified As Financing Activities 863,000.00 1,240,000.00 1,490,000.00
Cash Flows From Used In Financing Activities -2,172,000.00 -1,240,000.00 -1,490,000.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes 13,725,000.00 -168,000.00 -14,517,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents -276,000.00 153,000.00 2,000.00
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes 22,127,000.00 22,112,000.00 N/A
Cash and cash equivalents 22,127,000.00 22,112,000.00 7,597,000.00

Please note that some sums might not add up.

Filings & Publications

Insider Trades

Date Trading entity / Person Association Trade type Volume
05.05.23 Peter Edwall Other Buy SEK 320,470.35
05.05.23 Peter Edwall Other Buy SEK 102,295.04
21.09.22 Peter Edwall Other Sell SEK 102,295.04
01.06.21 Peter Edwall Other Buy SEK 40,958.50

Capital markets information

ISIN

SE0000188930

LEI

549300AVDV7UC14MTH79

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Sub-Industry

Health Care Equipment

Listed Stock Exchange

Nasdaq Stockholm

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.